Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The expression of the transmembrane protein 25 gene (Tmem25) is strongly influenced by glutamate ionotropic receptor kainate type subunit 4, and its function remains unknown. Here, we showed that
TMEM25
was primarily localized to late endosomes in neurons. Electrophysiological experiments suggested that the effects of
TMEM25
on neuronal excitability were likely mediated by N-methyl-d-aspartate receptors.
TMEM25
affected the expression of the N-methyl-d-aspartate receptor NR2B subunit and interacted with NR2B, and both were colocalized to late endosome compartments.
TMEM25
induced acidification changes in lysosome compartments and accelerated the degradation of NR2B. Furthermore,
TMEM25
expression was decreased in brain tissues from patients with epilepsy and epileptic mice.
TMEM25
overexpression attenuated the behavioral phenotypes of epileptic
seizures
, whereas
TMEM25
downregulation exerted the opposite effect. These results provide some insights into
TMEM25
biology in the brain and the functional relationship between
TMEM25
and epilepsy.
...
PMID:TMEM25 modulates neuronal excitability and NMDA receptor subunit NR2B degradation. 3142 25